Autoimmune neuropathies: Insights from animal models

Journal of the Peripheral Nervous System

Volumn 17, Issue SUPPL. 2, 2012, Pages 28-33

  Soliven, Betty ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

B7; CIDP; EAN; GBS; myelin P0; SAP

Indexed keywords

3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ANTIGEN; CELECOXIB; ECULIZUMAB; ENTINOSTAT; FINGOLIMOD; MELOXICAM; MEVINOLIN; MIROCOCEPT; NAFAMSTAT;

ACUTE MOTOR AXONAL NEUROPATHY; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; EXPERIMENTAL AUTOIMMUNE NEURITIS; GUILLAIN BARRE SYNDROME; KNOCKOUT MOUSE; NEUROPATHY; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SPONTANEOUS AUTOIMMUNE POLYNEUROPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84860621746     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2012.00392.x     Document Type: Review

References (74)

1. Abromson-Leeman S, Bronson R, Dorf ME, (1995). Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones. J Exp Med 182: 587-592.
2. Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, Hughes RA, (2005). Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 10: 174-180. (Pubitemid 40984891)
3. Anderson MS, Bluestone JA, (2005). The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485. (Pubitemid 40563177)
4. Bao L, Lindgren JU, Zhu Y, Ljunggren HG, Zhu J, (2003). Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiol Dis 12: 73-81. (Pubitemid 36259969)
5. Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA, (2004). Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J Clin Invest 114: 979-987. (Pubitemid 39578726)
6. Bour-Jordan H, Thompson HL, Bluestone JA, (2005). Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice. J Immunol 175: 5649-5655. (Pubitemid 41508046)
7. Brosnan JV, Craggs RI, King RH, Thomas PK, (1987). Reduced susceptibility of T cell-deficient rats to induction of experimental allergic neuritis. J Neuroimmunol 14: 267-282. (Pubitemid 17045916)
8. Brostoff SW, Levit S, Powers JM, (1977). Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein. Nature 268: 752-753. (Pubitemid 8157422)
9. Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, Apte RS, (2009). Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy. PLoS One 4: e7121.
10. Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, Gray GS, Nadler LM, (1993). Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262: 909-911. (Pubitemid 24014081)
11. Gabriel CM, Hughes RA, Moore SE, Smith KJ, Walsh FS, (1998). Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 121: 1895-1902. (Pubitemid 28454359)
12. Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Plomp JJ, Willison HJ, (2005). Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25: 1620-1628. (Pubitemid 40279266)
13. Halstead SK, O'Hanlon GM, Humphreys PD, Morrison DB, Morgan BP, Todd AJ, Plomp JJ, Willison HJ, (2004). Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127: 2109-2123. (Pubitemid 39150268)
14. Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ, (2005). Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 58: 203-210. (Pubitemid 41098878)
15. Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ, (2008). Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131: 1197-1208.
16. Hays AP, Latov N, Takatsu M, Sherman WH, (1987). Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 37: 242-256. (Pubitemid 17015497)
17. Ho TW, McKhann GM, Griffin JW, (1998). Human autoimmune neuropathies. Annu Rev Neurosci 21: 187-226. (Pubitemid 28150663)
18. Horste GM, El-Haddad H, Mausberg AK, Martin S, Hartung HP, Kieseier B, (2010). Spontaneous demyelinating autoimmune neuropathy in ICAM-1 deficient NOD mice. Neurol 74:A490 (Abs).
19. Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H, (2007). Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology 68: 277-282. (Pubitemid 46148339)
20. Jander S, Pohl J, Gillen C, Stoll G, (1996). Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res 43: 254-259. (Pubitemid 26044239)
21. Jung S, Gaupp S, Korn T, Kollner G, Hartung HP, Toyka KV, (2004). Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization. J Neurosci Res 75: 524-535. (Pubitemid 38165360)
22. Khalili-Shirazi A, Atkinson P, Gregson N, Hughes RA, (1993). Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 46: 245-251.
23. Khoury SJ, Sayegh MH, (2004). The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20: 529-538. (Pubitemid 38638123)
24. Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP, (2000). Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry 69: 362-368. (Pubitemid 30636240)
25. Kim HJ, Jung CG, Jensen MA, Dukala D, Soliven B, (2008). Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy. J Immunol 181: 8753-8760.
26. Kim HJ, Jung CG, Dukala D, Bae H, Kakazu R, Wollmann R, Soliven B, (2009). Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy. J Neuroimmunol 214: 93-100.
27. Koller H, Kieseier BC, Jander S, Hartung HP, (2005). Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352: 1343-1356.
28. Kusunoki S, Shimizu J, Chiba A, Ugawa Y, Hitoshi S, Kanazawa I, (1996). Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39: 424-431. (Pubitemid 26117997)
29. Lassmann H, Fierz W, Neuchrist C, Meyermann R, (1991). Chronic relapsing experimental allergic neuritis induced by repeated transfer of P2-protein reactive T cell lines. Brain 114: 429-442.
30. Ledbetter JA, Imboden JB, Schieven GL, Grosmaire LS, Rabinovitch PS, Lindsten T, Thompson CB, June CH, (1990). CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 75: 1531-1539. (Pubitemid 20114894)
31. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H, (1984). A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 133: 1946-1950. (Pubitemid 14035291)
32. Louvet C, Kabre BG, Davini DW, Martinier N, Su MA, DeVoss JJ, Rosenthal WL, Anderson MS, Bour-Jordan H, Bluestone JA, (2009). A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy. J Exp Med 206: 507-514.
33. Maurer M, Toyka KV, Gold R, (2002). Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscul Disord 12: 405-414. (Pubitemid 34327217)
34. McCombe PA, Harness J, Pender MP, (1999). Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol 97: 60-69. (Pubitemid 29301414)
35. Milner P, Lovelidge CA, Taylor WA, Hughes RA, (1987). P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 79: 275-285. (Pubitemid 17081180)
36. Miyamoto K, Oka N, Kawasaki T, Miyake S, Yamamura T, Akiguchi I, (2002). New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis. Muscle Nerve 25: 280-282. (Pubitemid 34117077)
37. Monaco S, Ferrari S, Bonetti B, Moretto G, Kirshfink M, Nardelli E, Nobile-Orazio E, Zanusso G, Rizzuto N, Tedesco F, (1995). Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex. J Neuropathol Exp Neurol 54: 96-104.
38. Oono T, Fukui Y, Masuko S, Hashimoto O, Ueno T, Sanui T, Inayoshi A, Noda M, Sata M, Sasazuki T, (2001). Organ-specific autoimmunity in mice whose T cell repertoire is shaped by a single antigenic peptide. J Clin Invest 108: 1589-1596. (Pubitemid 33144869)
39. Phongsisay V, Susuki K, Matsuno K, Yamahashi T, Okamoto S, Funakoshi K, Hirata K, Shinoda M, Yuki N, (2008). Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barre syndrome. J Neuroimmunol 205: 101-104.
40. Plomp JJ, Willison HJ, (2009). Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol 587: 3979-3999.
41. Plomp JJ, Molenaar PC, O'Hanlon GM, Jacobs BC, Veitch J, Daha MR, van Doorn PA, van der Meche FG, Vincent A, Morgan BP, Willison HJ, (1999). Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. Ann Neurol 45: 189-199. (Pubitemid 29072365)
42. Rinaldi S, Willison HJ, (2008). Ganglioside antibodies and neuropathies. Curr Opin Neurol 21: 540-546.
43. Rostami A, Gregorian SK, Brown MJ, Pleasure DE, (1990). Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein. J Neuroimmunol 30: 145-151. (Pubitemid 20362747)
44. Saida T, Saida K, Dorfman SH, Silberberg DH, Sumner AJ, Manning MC, Lisak RP, Brown MJ, (1979). Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 204: 1103-1106. (Pubitemid 10199159)
45. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA, (2000). B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
46. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA, (2001). Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194: 677-684. (Pubitemid 32844777)
47. Sanvito L, Makowska A, Mahdi-Rogers M, Hadden RD, Peakman M, Gregson N, Nemni R, Hughes RA, (2009). Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 80: 333-338.
48. Sarkey JP, Richards MP, Stubbs EB Jr, (2007). Lovastatin attenuates nerve injury in an animal model of Guillain-Barre syndrome. J Neurochem 100: 1265-1277.
49. Schmidt J, Elflein K, Stienekemeier M, Rodriguez-Palmero M, Schneider C, Toyka KV, Gold R, Hunig T, (2003). Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. J Neuroimmunol 140: 143-152. (Pubitemid 36836099)
50. Setoguchi R, Hori S, Takahashi T, Sakaguchi S, (2005). Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J Exp Med 201: 723-735. (Pubitemid 40395118)
51. Stoll G, Schwendemann G, Heininger K, Kohne W, Hartung HP, Seitz R, Toyka KV, (1986). Relation of clinical, serological, morphological, and electrophysiological findings in galactocerebroside-induced experimental allergic neuritis. J Neurol Neurosurg Psychiatry 49: 258-264. (Pubitemid 16124261)
52. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N, (2007). Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27: 3956-3967. (Pubitemid 46597169)
53. Tatum AH, (1993). Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol 33: 502-506. (Pubitemid 23143034)
54. Taylor JM, Pollard JD, (2007). Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation. J Neuroimmunol 183: 118-124. (Pubitemid 46204916)
55. Townson K, Boffey J, Nicholl D, Veitch J, Bundle D, Zhang P, Samain E, Antoine T, Bernardi A, Arosio D, Sonnino S, Isaacs N, Willison HJ, (2007). Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology 17: 294-303. (Pubitemid 46344681)
56. Waksman BH, Adams RD, (1955). Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102: 213-236.
57. Weerth S, Berger T, Lassmann H, Linington C, (1999). Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. J Neuroimmunol 95: 157-164. (Pubitemid 29173033)
58. Weishaupt A, Schonrock LM, Stienekemeier M, Toyka KV, Gold R, (2001). Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ. Acta Neuropathol (Berl) 102: 75-82. (Pubitemid 32734268)
59. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, Nomura T, Sakaguchi S, (2008). CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
60. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, Gold R, (2000). Regulation of Fas and FasL expression on rat Schwann cells. Glia 30: 373-381. (Pubitemid 30334338)
61. Yadav D, Sarvetnick N, (2007). Immunomodulation of the anti-islet CD8 T cell response by B7 2. J Clin Immunol 27: 221-226. (Pubitemid 46348723)
62. Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N, (2004). B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol 173: 3631-3639. (Pubitemid 39280722)
63. Yan WX, Archelos JJ, Hartung HP, Pollard JD, (2001). P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50: 286-292. (Pubitemid 32848730)
64. Yu S, Chen Z, Mix E, Zhu SW, Winblad B, Ljunggren HG, Zhu J, (2002). Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen. J Neuropathol Exp Neurol 61: 614-622. (Pubitemid 34721466)
65. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K, (2001). Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49: 712-720. (Pubitemid 32530237)
66. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M, (2004). Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 101: 11404-11409. (Pubitemid 39038359)
67. Zeng M, Guinet E, Nouri-Shirazi M, (2009). B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+) Foxp3(+) regulatory T cells. Transpl Immunol 20: 171-179.
68. Zetti UK, Gold R, Toyka KV, Hartung HP, (1996). In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol 91: 360-367. (Pubitemid 26088971)
69. Zhang Z, Zhang ZY, Fauser U, Schluesener HJ, (2008). FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp Neurol 210: 681-690.
70. Zhang ZY, Zhang Z, Zug C, Nuesslein-Hildesheim B, Leppert D, Schluesener HJ, (2009). AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis. J Neuroimmunol 216: 59-65.
71. Zhang ZY, Zhang Z, Schluesener HJ, (2010). MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 169: 370-377.
72. Zhu J, Bai XF, Mix E, Link H, (1997). Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol 84: 85-94. (Pubitemid 27293547)
73. Zhu Y, Ljunggren H, Mix E, Li HL, van der Meide P, Elhassan AM, Winblad B, Zhu J, (2001). CD28-B7 costimulation: a critical role for initiation and development of experimental autoimmune neuritis in C57BL/6 mice. J Neuroimmunol 114: 114-121. (Pubitemid 32184732)
74. Zou LP, Ljunggren HG, Levi M, Nennesmo I, Wahren B, Mix E, Winblad B, Schalling M, Zhu J, (2000). P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice. J Neurosci Res 62: 717-721.